Onderneming Unichem Laboratories Limited NSE India S.E.
Aandelen
UNICHEMLAB
INE351A01035
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
555,4 INR | -0,69% | -1,57% | +36,82% |
Vakgebied
Aantal werknemers: 2 894
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Formulations
86,2
%
| 10 969 | 86,4 % | 11 582 | 86,2 % | +5,60% |
Bulk Drugs and Chemicals
10,7
%
| 1 511 | 11,9 % | 1 442 | 10,7 % | -4,59% |
Other
1,7
%
| 119 | 0,9 % | 230 | 1,7 % | +93,92% |
Export Benefits
1,3
%
| 100 | 0,8 % | 176 | 1,3 % | +76,18% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
60,3
%
| 7 343 | 58,8 % | 7 856 | 60,3 % | +6,98% |
Others
37,2
%
| 4 724 | 37,9 % | 4 846 | 37,2 % | +2,58% |
India
2,5
%
| 413 | 3,3 % | 322 | 2,5 % | -21,92% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 55 | 10-08-23 | |
Sandip Ghume
DFI | Director of Finance/CFO | - | 30-10-18 |
Chairman | 71 | 22-08-77 | |
Pradeep Bhandari
CMP | Compliance Officer | - | 01-08-19 |
Dilip Bhor
IRO | Public Communications Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Pranay Godha
BRD | Director/Board Member | 51 | 10-08-23 |
Director/Board Member | 75 | - | |
Chairman | 71 | 22-08-77 | |
Director/Board Member | 66 | - | |
Chief Executive Officer | 55 | 10-08-23 | |
Priti Puri
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 70 405 750 | 20 283 296 ( 28,81 %) | 0 | 28,81 % |
Bedrijfsgegevens
Unichem Laboratories Ltd.
Unichem Bhavan Prabhat Estate, Off. S.V. Road
400102, Mumbai
+91 22 6688 8333
http://www.unichemlabs.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Niche Generics Ltd.
Niche Generics Ltd. Medical DistributorsDistribution Services Niche Generics Ltd. marketed and distributed pharmaceutical products. It offered antifungal, antineoplastic, antispasmodic/anticholinergic, cardiovascular system, and central nervous system, as well as pain, analgesic, and antipyretic products. The firm products are supplied via wholesalers in the United Kingdom; sales in Europe; and selected partners to other territories. The company was founded on January 15, 2002 and was headquartered in Hitchin, the United Kingdom. |
Medical Distributors
|
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,06% | 682 mld. | |
+30,35% | 586 mld. | |
-3,42% | 364 mld. | |
+18,02% | 327 mld. | |
+4,27% | 285 mld. | |
+15,53% | 240 mld. | |
+10,16% | 209 mld. | |
-8,14% | 203 mld. | |
+8,12% | 165 mld. |
- Beurs
- Aandelen
- Koers UNICHEMLAB
- Koers UNICHEMLAB
- Onderneming Unichem Laboratories Limited